Author

H. G. Choi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

A. R. Fullen· 1 shared C. F. Love· 1 shared D. Raju· 1 shared J. L. Gutierrez-Ferman· 1 shared J. Ni· 1 shared J. Zhao· 1 shared K. N. Corps· 1 shared K. S. Yount· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. R. Fullen

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologybioRxivApr 6, 2022

Bps polysaccharide of Bordetella pertussis resists antimicrobial peptides by functioning as a dual surface shield and decoy and converts Escherichia coli into a respiratory pathogen.

A. R. Fullen, J. L. Gutierrez-Ferman, K. S. Yount…·R. Deora

DOI 10.1371/journal.ppat.1010764

mouseexperimental assay

𝕏 PostBluesky

Pharmacology & ToxicologybioRxivPreprintMar 9, 2020

CM93, a novel covalent small molecule inhibitor targeting lung cancer with mutant EGFR

Q. Wang, J. Ni, T. Jiang…·J. Zhao

The paper develops CM93, a novel EGFR inhibitor with improved targeting and brain penetration, showing better efficacy and safety in mouse models of EGFR-mutant NSCLC and brain metastases.

DOI 10.1101/2020.03.09.984500

mouseexperimental assay

𝕏 PostBluesky